Sandbox: Gertrude: Difference between revisions

Jump to navigation Jump to search
← Older editNewer edit →
VisualWikitext
No edit summary
No edit summary
Line 5: Line 5:
{{CMG}}; {{AE}}, {{G.D.}}
{{CMG}}; {{AE}}, {{G.D.}}


  ==Differentiating neck masses from other Diseases==
  Differential diagnosis of neck masses==
Differential diagnosis of neck masses include:
Differential diagnosis of neck masses include:
{|
{|
! rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Category
! rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Category
! colspan="2" rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diseases
! colspan="2" rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diseases
! rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Etiology
! rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Benign or Malignant
! rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Benign
! colspan="8" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Clinical manifestation
! rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Malignant
! colspan="9" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Clinical manifestation
! colspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Paraclinical findings
! colspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Paraclinical findings
! rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Gold standard diagnosis
! rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Gold standard diagnosis
Line 20: Line 18:
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Demography
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Demography
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |History
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |History
! colspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Symptoms
! colspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Symptoms
! colspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Signs
! colspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Signs
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Lab findings
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Lab findings
Line 26: Line 24:
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Imaging
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Imaging
|-
|-
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Mass
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Pain
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Pain
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Dysphagia
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Dysphagia
Line 36: Line 33:
! rowspan="10" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Congenital
! rowspan="10" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Congenital
! colspan="2" align="center" style="background:#DCDCDC;" |Branchial cleft cyst
! colspan="2" align="center" style="background:#DCDCDC;" |Branchial cleft cyst
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |Benign
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 55: Line 49:
|-
|-
! colspan="2" align="center" style="background:#DCDCDC;" |Thyroglossal duct cyst
! colspan="2" align="center" style="background:#DCDCDC;" |Thyroglossal duct cyst
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 74: Line 65:
|-
|-
! colspan="2" align="center" style="background:#DCDCDC;" |Hemangioma
! colspan="2" align="center" style="background:#DCDCDC;" |Hemangioma
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 93: Line 81:
|-
|-
! colspan="2" align="center" style="background:#DCDCDC;" |Vascular malformations
! colspan="2" align="center" style="background:#DCDCDC;" |Vascular malformations
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 112: Line 97:
|-
|-
! colspan="2" align="center" style="background:#DCDCDC;" |Lymphatic malformations
! colspan="2" align="center" style="background:#DCDCDC;" |Lymphatic malformations
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 131: Line 113:
|-
|-
! colspan="2" align="center" style="background:#DCDCDC;" |Laryngocele
! colspan="2" align="center" style="background:#DCDCDC;" |Laryngocele
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 150: Line 129:
|-
|-
! colspan="2" align="center" style="background:#DCDCDC;" |Ranula
! colspan="2" align="center" style="background:#DCDCDC;" |Ranula
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 169: Line 145:
|-
|-
! colspan="2" align="center" style="background:#DCDCDC;" |Teratoma
! colspan="2" align="center" style="background:#DCDCDC;" |Teratoma
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 188: Line 161:
|-
|-
! colspan="2" align="center" style="background:#DCDCDC;" |Dermoid cyst
! colspan="2" align="center" style="background:#DCDCDC;" |Dermoid cyst
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 207: Line 177:
|-
|-
! colspan="2" align="center" style="background:#DCDCDC;" |Thymic cyst
! colspan="2" align="center" style="background:#DCDCDC;" |Thymic cyst
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 227: Line 194:
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Category
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Category
! colspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diseases
! colspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diseases
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Etiology
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Benign or Malignant
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Benign
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Malignant
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Demography
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Demography
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |History
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |History
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Mass
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Pain
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Pain
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Dysphagia
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Dysphagia
Line 247: Line 211:
| rowspan="21" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Inflammatory
| rowspan="21" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Inflammatory
! colspan="2" align="center" style="background:#DCDCDC;" |Acute sialadenitis
! colspan="2" align="center" style="background:#DCDCDC;" |Acute sialadenitis
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 266: Line 227:
|-
|-
! colspan="2" align="center" style="background:#DCDCDC;" |Chronic sialadenitis
! colspan="2" align="center" style="background:#DCDCDC;" |Chronic sialadenitis
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 286: Line 244:
! rowspan="4" align="center" style="background:#DCDCDC;" |Reactive viral lymphadenopathy
! rowspan="4" align="center" style="background:#DCDCDC;" |Reactive viral lymphadenopathy
! align="center" style="background:#DCDCDC;" |CMV
! align="center" style="background:#DCDCDC;" |CMV
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 305: Line 260:
|-
|-
! align="center" style="background:#DCDCDC;" |EBV
! align="center" style="background:#DCDCDC;" |EBV
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 324: Line 276:
|-
|-
! align="center" style="background:#DCDCDC;" |HIV
! align="center" style="background:#DCDCDC;" |HIV
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 343: Line 292:
|-
|-
! align="center" style="background:#DCDCDC;" |Viral URI
! align="center" style="background:#DCDCDC;" |Viral URI
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 363: Line 309:
! rowspan="6" align="center" style="background:#DCDCDC;" |Bacterial lymphadenopathy
! rowspan="6" align="center" style="background:#DCDCDC;" |Bacterial lymphadenopathy
! align="center" style="background:#DCDCDC;" |Tularemia
! align="center" style="background:#DCDCDC;" |Tularemia
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 382: Line 325:
|-
|-
! align="center" style="background:#DCDCDC;" |Brucellosis
! align="center" style="background:#DCDCDC;" |Brucellosis
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 401: Line 341:
|-
|-
! align="center" style="background:#DCDCDC;" |Cat-scratch disease
! align="center" style="background:#DCDCDC;" |Cat-scratch disease
| align="center" style="background:#F5F5F5;" |
:* ''Bartonella henselae'' infection
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 421: Line 357:
|-
|-
! align="center" style="background:#DCDCDC;" |Actinomycosis  
! align="center" style="background:#DCDCDC;" |Actinomycosis  
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 440: Line 373:
|-
|-
! align="center" style="background:#DCDCDC;" |Mycobacterial infections  
! align="center" style="background:#DCDCDC;" |Mycobacterial infections  
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 459: Line 389:
|-
|-
! align="center" style="background:#DCDCDC;" |Staphylococcal or streptococcal infection
! align="center" style="background:#DCDCDC;" |Staphylococcal or streptococcal infection
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 479: Line 406:
! align="center" style="background:#DCDCDC;" |Parasitic lymphadenopathy
! align="center" style="background:#DCDCDC;" |Parasitic lymphadenopathy
! align="center" style="background:#DCDCDC;" |Toxoplasma gondii
! align="center" style="background:#DCDCDC;" |Toxoplasma gondii
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 498: Line 422:
|-
|-
! colspan="2" align="center" style="background:#DCDCDC;" |Sarcoidosis
! colspan="2" align="center" style="background:#DCDCDC;" |Sarcoidosis
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 517: Line 438:
|-
|-
! colspan="2" align="center" style="background:#DCDCDC;" |Amyloidosis
! colspan="2" align="center" style="background:#DCDCDC;" |Amyloidosis
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 536: Line 454:
|-
|-
! colspan="2" align="center" style="background:#DCDCDC;" |Sjögren syndrome
! colspan="2" align="center" style="background:#DCDCDC;" |Sjögren syndrome
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 555: Line 470:
|-
|-
! colspan="2" align="center" style="background:#DCDCDC;" |Castleman disease (angiofollicular lymphoproliferative disease)
! colspan="2" align="center" style="background:#DCDCDC;" |Castleman disease (angiofollicular lymphoproliferative disease)
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 574: Line 486:
|-
|-
! colspan="2" align="center" style="background:#DCDCDC;" |Kikuchi disease (histiocytic necrotizing lymphadenitis)
! colspan="2" align="center" style="background:#DCDCDC;" |Kikuchi disease (histiocytic necrotizing lymphadenitis)
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 593: Line 502:
|-
|-
! colspan="2" align="center" style="background:#DCDCDC;" |Kimura disease
! colspan="2" align="center" style="background:#DCDCDC;" |Kimura disease
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 612: Line 518:
|-
|-
! colspan="2" align="center" style="background:#DCDCDC;" |Rosai-Dorfman disease
! colspan="2" align="center" style="background:#DCDCDC;" |Rosai-Dorfman disease
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 631: Line 534:
|-
|-
! colspan="2" align="center" style="background:#DCDCDC;" |Kawasaki disease
! colspan="2" align="center" style="background:#DCDCDC;" |Kawasaki disease
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 651: Line 551:
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Category
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Category
! colspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diseases
! colspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diseases
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Etiology
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Benign or Malignant
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Benign
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Malignant
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Demography
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Demography
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |History
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |History
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Mass
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Pain
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Pain
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Dysphagia
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Dysphagia
Line 671: Line 568:
! rowspan="20" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Neoplasm
! rowspan="20" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Neoplasm
! colspan="2" align="center" style="background:#DCDCDC;" |Primary thyroid tumor
! colspan="2" align="center" style="background:#DCDCDC;" |Primary thyroid tumor
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 691: Line 585:
! rowspan="10" align="center" style="background:#DCDCDC;" |Salivary gland neoplasm
! rowspan="10" align="center" style="background:#DCDCDC;" |Salivary gland neoplasm
! align="center" style="background:#DCDCDC;" |Pleomorphic adenoma
! align="center" style="background:#DCDCDC;" |Pleomorphic adenoma
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 710: Line 601:
|-
|-
! align="center" style="background:#DCDCDC;" |Warthin's tumor
! align="center" style="background:#DCDCDC;" |Warthin's tumor
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 729: Line 617:
|-
|-
! align="center" style="background:#DCDCDC;" |Lymphoepithelioma
! align="center" style="background:#DCDCDC;" |Lymphoepithelioma
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" | +
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 748: Line 633:
|-
|-
! align="center" style="background:#DCDCDC;" |Oncocytoma
! align="center" style="background:#DCDCDC;" |Oncocytoma
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 767: Line 649:
|-
|-
! align="center" style="background:#DCDCDC;" |Monomorphic adenoma
! align="center" style="background:#DCDCDC;" |Monomorphic adenoma
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 786: Line 665:
|-
|-
! align="center" style="background:#DCDCDC;" |Mucoepidermoid carcinoma
! align="center" style="background:#DCDCDC;" |Mucoepidermoid carcinoma
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 805: Line 681:
|-
|-
! align="center" style="background:#DCDCDC;" |Adenoid cystic carcinoma
! align="center" style="background:#DCDCDC;" |Adenoid cystic carcinoma
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 824: Line 697:
|-
|-
! align="center" style="background:#DCDCDC;" |Adenocarcinoma
! align="center" style="background:#DCDCDC;" |Adenocarcinoma
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 843: Line 713:
|-
|-
! align="center" style="background:#DCDCDC;" |Salivary duct carcinoma
! align="center" style="background:#DCDCDC;" |Salivary duct carcinoma
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 862: Line 729:
|-
|-
! align="center" style="background:#DCDCDC;" |Squamous cell carcinoma
! align="center" style="background:#DCDCDC;" |Squamous cell carcinoma
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 881: Line 745:
|-
|-
! colspan="2" align="center" style="background:#DCDCDC;" |Parathyroid tumors
! colspan="2" align="center" style="background:#DCDCDC;" |Parathyroid tumors
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 900: Line 761:
|-
|-
! colspan="2" align="center" style="background:#DCDCDC;" |Carotid body tumors
! colspan="2" align="center" style="background:#DCDCDC;" |Carotid body tumors
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 919: Line 777:
|-
|-
! colspan="2" align="center" style="background:#DCDCDC;" |Paraganglioma
! colspan="2" align="center" style="background:#DCDCDC;" |Paraganglioma
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 938: Line 793:
|-
|-
! colspan="2" align="center" style="background:#DCDCDC;" |Schwannoma
! colspan="2" align="center" style="background:#DCDCDC;" |Schwannoma
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 957: Line 809:
|-
|-
! colspan="2" align="center" style="background:#DCDCDC;" |Lymphoma
! colspan="2" align="center" style="background:#DCDCDC;" |Lymphoma
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 976: Line 825:
|-
|-
! colspan="2" align="center" style="background:#DCDCDC;" |Liposarcoma
! colspan="2" align="center" style="background:#DCDCDC;" |Liposarcoma
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 995: Line 841:
|-
|-
! colspan="2" align="center" style="background:#DCDCDC;" |Lipoma  
! colspan="2" align="center" style="background:#DCDCDC;" |Lipoma  
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 1,014: Line 857:
|-
|-
! colspan="2" align="center" style="background:#DCDCDC;" |Glomus vagale, glomus jugulare tumors
! colspan="2" align="center" style="background:#DCDCDC;" |Glomus vagale, glomus jugulare tumors
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 1,033: Line 873:
|-
|-
! colspan="2" align="center" style="background:#DCDCDC;" |Metastatic head and neck carcinoma
! colspan="2" align="center" style="background:#DCDCDC;" |Metastatic head and neck carcinoma
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 1,053: Line 890:
! rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other
! rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Other
! colspan="2" align="center" style="background:#DCDCDC;" |Hematoma
! colspan="2" align="center" style="background:#DCDCDC;" |Hematoma
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 1,072: Line 906:
|-
|-
! colspan="2" align="center" style="background:#DCDCDC;" |Arteriovenous fistula
! colspan="2" align="center" style="background:#DCDCDC;" |Arteriovenous fistula
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 1,091: Line 922:
|-
|-
! colspan="2" align="center" style="background:#DCDCDC;" |Goiter
! colspan="2" align="center" style="background:#DCDCDC;" |Goiter
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
| align="center" style="background:#F5F5F5;" |
Line 1,111: Line 939:
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Category
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Category
! colspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diseases
! colspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Diseases
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Etiology
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Benign
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Benign
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Malignant
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Demography
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Demography
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |History
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |History
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Mass
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Pain
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Pain
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Dysphagia
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Dysphagia
Line 1,130: Line 955:
|}
|}


== References ==
===References===
{{Reflist|2}}
{{reflist|2}}

Revision as of 20:35, 23 January 2019

Xyz Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Xyz from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Sandbox: Gertrude On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Sandbox: Gertrude

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Sandbox: Gertrude

CDC on Sandbox: Gertrude

Sandbox: Gertrude in the news

Blogs on Sandbox: Gertrude

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Sandbox: Gertrude

For patient information, click here

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: , Gertrude Djouka, M.D.[2] 

Differential diagnosis of neck masses==

Differential diagnosis of neck masses include:

Category Diseases Benign or Malignant Clinical manifestation Paraclinical findings Gold standard diagnosis Associated findings
Demography History Symptoms Signs Lab findings Histopathology Imaging
Pain Dysphagia Mass exam Skin changes LAP Others
Congenital Branchial cleft cyst Benign
Thyroglossal duct cyst
Hemangioma
Vascular malformations
Lymphatic malformations
Laryngocele
Ranula
Teratoma
Dermoid cyst
Thymic cyst
Category Diseases Benign or Malignant Demography History Pain Dysphagia Mass exam Skin changes LAP Others Lab findings Histopathology Imaging Gold standard diagnosis Associated findings
Inflammatory Acute sialadenitis
Chronic sialadenitis
Reactive viral lymphadenopathy CMV
EBV
HIV
Viral URI
Bacterial lymphadenopathy Tularemia
Brucellosis
Cat-scratch disease
Actinomycosis
Mycobacterial infections
Staphylococcal or streptococcal infection
Parasitic lymphadenopathy Toxoplasma gondii
Sarcoidosis
Amyloidosis
Sjögren syndrome
Castleman disease (angiofollicular lymphoproliferative disease)
Kikuchi disease (histiocytic necrotizing lymphadenitis)
Kimura disease
Rosai-Dorfman disease
Kawasaki disease
Category Diseases Benign or Malignant Demography History Pain Dysphagia Mass exam Skin changes LAP Others Lab findings Histopathology Imaging Gold standard diagnosis Associated findings
Neoplasm Primary thyroid tumor
Salivary gland neoplasm Pleomorphic adenoma +
Warthin's tumor +
Lymphoepithelioma +
Oncocytoma
Monomorphic adenoma
Mucoepidermoid carcinoma
Adenoid cystic carcinoma
Adenocarcinoma
Salivary duct carcinoma
Squamous cell carcinoma
Parathyroid tumors
Carotid body tumors
Paraganglioma
Schwannoma
Lymphoma
Liposarcoma
Lipoma
Glomus vagale, glomus jugulare tumors
Metastatic head and neck carcinoma
Other Hematoma
Arteriovenous fistula
Goiter
Category Diseases Benign Demography History Pain Dysphagia Mass exam Skin changes LAP Others Lab findings Histopathology Imaging Gold standard diagnosis Associated findings

References

Retrieved from "https://www.wikidoc.org/index.php?title=Sandbox:_Gertrude&oldid=1539874"